Market Closed -
Bombay S.E.
06:00:50 2024-04-26 am EDT
|
5-day change
|
1st Jan Change
|
138.4
INR
|
-1.39%
|
|
-0.47%
|
+10.59%
|
Fiscal Period: March |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Capitalization
1 |
2,800
|
3,138
|
945.4
|
3,112
|
6,550
|
5,478
|
Enterprise Value (EV)
1 |
3,628
|
4,313
|
2,280
|
4,553
|
8,563
|
7,735
|
P/E ratio
|
17.7
x
|
12.7
x
|
7.82
x
|
8.28
x
|
28.4
x
|
13.5
x
|
Yield
|
1.18%
|
1.06%
|
3.53%
|
1.25%
|
0.54%
|
0.65%
|
Capitalization / Revenue
|
0.79
x
|
0.64
x
|
0.2
x
|
0.58
x
|
0.83
x
|
0.58
x
|
EV / Revenue
|
1.02
x
|
0.88
x
|
0.48
x
|
0.84
x
|
1.09
x
|
0.82
x
|
EV / EBITDA
|
8.7
x
|
7.91
x
|
5.32
x
|
7.37
x
|
15
x
|
8.5
x
|
EV / FCF
|
-34
x
|
-12.3
x
|
-13
x
|
-35.6
x
|
-15.9
x
|
-38.9
x
|
FCF Yield
|
-2.95%
|
-8.16%
|
-7.72%
|
-2.81%
|
-6.27%
|
-2.57%
|
Price to Book
|
3.51
x
|
3.07
x
|
0.7
x
|
1.91
x
|
3.49
x
|
2.43
x
|
Nbr of stocks (in thousands)
|
65,834
|
66,698
|
66,698
|
70,698
|
70,698
|
70,698
|
Reference price
2 |
42.52
|
47.05
|
14.18
|
44.02
|
92.65
|
77.49
|
Announcement Date
|
9/4/18
|
7/19/19
|
9/5/20
|
7/15/21
|
8/20/22
|
9/5/23
|
Fiscal Period: March |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net sales
1 |
3,553
|
4,893
|
4,787
|
5,405
|
7,860
|
9,450
|
EBITDA
1 |
416.8
|
545.5
|
428.7
|
617.7
|
569.8
|
910.1
|
EBIT
1 |
294.2
|
407.4
|
234.4
|
547.6
|
471
|
779.5
|
Operating Margin
|
8.28%
|
8.33%
|
4.9%
|
10.13%
|
5.99%
|
8.25%
|
Earnings before Tax (EBT)
1 |
250
|
378.7
|
183.4
|
489.9
|
345.1
|
567.9
|
Net income
1 |
159.9
|
247.9
|
128.1
|
376
|
230.5
|
404.3
|
Net margin
|
4.5%
|
5.07%
|
2.68%
|
6.96%
|
2.93%
|
4.28%
|
EPS
2 |
2.397
|
3.717
|
1.813
|
5.318
|
3.260
|
5.719
|
Free Cash Flow
1 |
-106.8
|
-352
|
-176
|
-127.9
|
-537.1
|
-198.8
|
FCF margin
|
-3.01%
|
-7.19%
|
-3.68%
|
-2.37%
|
-6.83%
|
-2.1%
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
-
|
-
|
-
|
Dividend per Share
2 |
0.5000
|
0.5000
|
0.5000
|
0.5500
|
0.5000
|
0.5000
|
Announcement Date
|
9/4/18
|
7/19/19
|
9/5/20
|
7/15/21
|
8/20/22
|
9/5/23
|
Fiscal Period: March |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net Debt
1 |
828
|
1,175
|
1,335
|
1,441
|
2,013
|
2,257
|
Net Cash position
1 |
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
1.987
x
|
2.154
x
|
3.113
x
|
2.333
x
|
3.533
x
|
2.48
x
|
Free Cash Flow
1 |
-107
|
-352
|
-176
|
-128
|
-537
|
-199
|
ROE (net income / shareholders' equity)
|
21.3%
|
27.1%
|
9.89%
|
25.3%
|
13.2%
|
19.8%
|
ROA (Net income/ Total Assets)
|
7.39%
|
9%
|
4.14%
|
8.4%
|
5.84%
|
8.46%
|
Assets
1 |
2,164
|
2,755
|
3,094
|
4,475
|
3,946
|
4,779
|
Book Value Per Share
2 |
12.10
|
15.30
|
20.20
|
23.00
|
26.60
|
31.90
|
Cash Flow per Share
2 |
1.160
|
1.400
|
1.460
|
2.140
|
0.8500
|
0.8800
|
Capex
1 |
215
|
435
|
369
|
504
|
397
|
313
|
Capex / Sales
|
6.04%
|
8.89%
|
7.7%
|
9.33%
|
5.05%
|
3.32%
|
Announcement Date
|
9/4/18
|
7/19/19
|
9/5/20
|
7/15/21
|
8/20/22
|
9/5/23
|
|
1st Jan change
|
Capi.
|
---|
| +10.59% | 117M | | -0.19% | 74.89B | | +0.09% | 46.52B | | -4.19% | 30.82B | | +9.85% | 18.19B | | -10.05% | 11.54B | | +6.39% | 11.24B | | -8.09% | 9.73B | | +2.79% | 9.4B | | +6.35% | 9.37B |
Diversified Chemicals
|